Moreover, activation of astroglial TFEB resulted in the clearance of extracellular tau through lysosomal degradation, contributing to the reduction of tau spreading [362], which supports a neuroprotective effect of TFEB modulation in AD tau pathology. The gene discussed is TFEB; the disease is Alzheimer disease.